Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of ll-37 amide (human cathelicidin antimicrobial peptide) in China, also supports custom service. Welcome to wholesale bulk high quality ll-37 amide (human cathelicidin antimicrobial peptide) from our factory. Contact us for more details.
| Description | LL-37 amide (CAS: 597562-32-8) is a C-terminally amidated analog of human cathelicidin LL-37, sequence LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-NH2. Molecular formula C205H341N61O52, MW 4492.28 Da. Native LL-37 is the sole human cathelicidin, 37 residues long with an N-terminal double-leucine start (LL), and is a core effector molecule of human innate immunity. C-terminal amidation neutralizes the terminal carboxylate negative charge, enhancing peptide positive charge and membrane binding while increasing resistance to carboxypeptidase degradation. LL-37 amide retains the broad-spectrum antibacterial (Gram-positive/Gram-negative, fungi, viruses), immunomodulatory, and anticancer activities of native LL-37, serving as a commonly used stabilized tool peptide for studying human innate immunity and LL-37 structure-activity relationships. |
| Structure type | Linear 37-mer (human LL-37 C-amidated alpha-helical cathelicidin analog) |
| Solubility | Readily soluble in water, dilute acetic acid |
| Storage | Powder -20C, dry, protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| LL-37 amide (human cathelicidin antimicrobial peptide) | LL-37-NH₂; hCAP-18-derived peptide; CAP-18 fragment | Antimicrobial, antibacterial, antifungal, antiviral, immunomodulatory, wound healing, anti-biofilm, host defense | Linear 37-aa cationic amphipathic α-helical host defense peptide; C-terminal carboxyl amidated (–CONH₂); net charge ~+6 (5 Arg + 6 Lys − 2 Asp − 3 Glu); rich in Phe (4 residues) forming hydrophobic face; no Cys/Met/Trp; intrinsically disordered in water, folds into amphipathic α-helix upon membrane or ethanol/salt contact | C₂₀₅H₃₄₁N₆₁O₅₂ (amide form) | 4489.59 | 4492.36 | TFA salt (most common commercial form; acetate salt preferred for cell/in vivo studies) | 37 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-LL37-01 | White powder | Store at -20°C, sealed, desiccated, protected from light (~2 years). Aliquot to avoid repeated freeze-thaw. No Met/Cys/Trp-low oxidation risk, but prone to self-aggregation at high ionic strength. | 2–8°C for up to ~1 month; working aliquots at -20°C; stable for shipping at ambient. | Cationic amphipathic helical peptide; good water solubility (aqueous buffers ≥1–5 mg/mL; ~50 mg/mL in DMSO with sonication). KEY NOTE: At high ionic strength (physiological 150 mM NaCl), the peptide self-aggregates into oligomers, reducing antimicrobial activity-prepare working solutions in low-ionic-strength buffer or with 0.01% acetic acid. No Cys (no disulfide issues), no Met (no oxidation), no Trp. Strongly hygroscopic-moisture/light causes gradual activity loss. | solid stable for ~2 years at -20°C, sealed and desiccated. Strongly hygroscopic-keep desiccator sealed. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-LL37-01 | The C-terminal-amidated form of human cathelicidin LL-37, a broad-spectrum cationic amphipathic α-helical antimicrobial and immunomodulatory host defense peptide that promotes wound healing and anti-biofilm activity. | LL-37 amide retains the broad-spectrum antimicrobial activity of native LL-37 against Gram-positive bacteria (S. aureus, group A Streptococcus), Gram-negative bacteria (E. coli, P. aeruginosa), fungi (C. albicans), and enveloped viruses (HIV, influenza). C-terminal amidation enhances enzymatic stability and membrane interaction. Beyond direct killing, LL-37 is a key immunomodulator: it chemoattracts immune cells through the FPRL1/FPR2 receptor, modulates LPS/TLR4 signaling, promotes angiogenesis and keratinocyte migration, and is critical in wound healing. It also inhibits bacterial biofilm formation and has advanced into preclinical studies for various infectious and inflammatory conditions. The amidated form offers improved proteolytic stability over the free acid. | Innate immunity, antimicrobial resistance, wound healing, mucosal infection, biofilm inhibition, inflammation, host-pathogen interactions, peptide drug development | Bacterial/anionic lipid membranes (pore/barrier disruption); FPRL1/FPR2 chemotactic receptor; LPS/TLR4 signaling modulation; epithelial migration and angiogenesis pathways |
Hot Tags: ll-37 amide (human cathelicidin antimicrobial peptide), China ll-37 amide (human cathelicidin antimicrobial peptide) manufacturers, suppliers, factory, 143459-88-5, CAS 143459 88 5, CAS 849352 44 9, Cilofungin, Combi-1, Elf18
